EHR validation in 406,230 “relaxed” and 127,151 “strict” patients showed stable PREVENT discrimination across sexes, ...
A breast cancer diagnosis doesn't land only on the patient, but rather it ripples through an entire household. In this ...
A 1000 mg ×2 induction regimen followed by maintenance every 6–12 months was associated with near-elimination of relapse ...
Prior authorization was rated a major burden by 32% of insured adults and the single greatest barrier by 34%, surpassing ...
A new case-control study published in JAMA Cardiology demonstrates that molecular imaging using gallium-68–labeled fibroblast ...
Wakely’s insurer-based dataset covering ~80% of Marketplace enrollment found approximately 1 in 7 new-year enrollees did not ...
The 340B Drug Pricing Program remains one of the most important structural supports for health systems across the US, ...
Midterm messaging is likely to center on health care costs, with Republicans emphasizing DTC drug models and MFN pricing ...
Embedded supportive care programs deliver measurable improvements, but fee-for-service economics prevent scaling because ...
John Barkett, MBA, discusses recent regulatory proposals to make massive health plan price files more usable. Price ...
Esketamine first received FDA approval in 2019, but with an important restriction: it could only be used in combination with an oral antidepressant. That requirement, built into the original label and ...
As cell and gene therapies (CGTs) continue to receive regulatory approvals at an accelerating pace, health care institutions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results